July 2023 – Prof. Andreas Birkenfeld discusses 10 common prejudices about obesity
Eternygen´s founder Prof. Andreas Birkenfeld discusses 10 common prejudices about obesity. (in German) Find the video here.
Author: eternygenFlorian
August 2023 – Eternygen published new data: citrate transporter INDY/NaCT/SLC13A5 as a therapeutic target for kidney diseases
In collaboration with Dipender Gill and Stephen Burgess, we've identified a noteworthy new connection between hepatic INDY/SLC13A5 and kidney function. This [...]
August 2023 – Meet the Eternygen team at the “Aging research and drug discovery meeting” in Copenhagen from 28 Aug to 1 Sep
Meet the Eternygen team at the “Aging research and drug discovery meeting” in Copenhagen from 28 Aug to 1 Sep [...]
July 2023 – Prof. Andreas Birkenfeld discusses 10 common prejudices about obesity
Eternygen´s founder Prof. Andreas Birkenfeld discusses 10 common prejudices about obesity. (in German) Find the video here.
March 2023 – Eternygen at BioEuropeSpring conference
Meet Eternygen at BioEuropeSpring conference in Basel from 20-22 March 2023 More information here.
October 2022 – Eternygen at BioEurope conference
Meet Eternygen at BioEurope conference in Leipzig from 23-26 October 2022 More information here.
September 2022 – Grit Zahn presents at TESS Research Foundation’s International Research Conference and biotx.ai in September
Grit Zahn, Head of Research of Eternygen GmbH will be speaking at TESS Research Foundation's International Research Conference in Vienna [...]
August 2022 – Eternygen at the “Aging research and drug discovery meeting” in Copenhagen
Meet the Eternygen team at the “Aging research and drug discovery meeting” in Copenhagen from August 28th to 1 September. [...]
August 2022 – Eternygen published new paper on SLC13A5 inhibitors
Eternygen published new paper on SLC13A5 inhibitors titled: “A Novel and Cross-Species Active Mammalian INDY (NaCT) Inhibitor Ameliorates Hepatic Steatosis [...]
April 2022 – Andreas Birkenfeld and Dr. Grit Zahn are Guest editing a Special Issue on “I’m Not Dead Yet in Metabolic Regulation”
Andreas Birkenfeld and Dr. Grit Zahn are Guest editing a Special Issue on “I'm Not Dead Yet in Metabolic Regulation” [...]
November 2021 – Prof. Birkenfeld featured in german TV ZDF Series “Auf der Suche nach dem ewigen Leben”
Eternygen Co-Founder Andreas Birkenfeld is featured in the German TV ZDF Series "Auf der Suche nach dem ewigen Leben" and [...]
January 2021 – Prof. Birkenfeld publishes new paper regarding the role of mIndy/NaCT for blood pressure titled „The longevity gene mIndy (I’m Not Dead, Yet) affects blood pressure through sympathoadrenal mechanisms.”
Link to Paper Eternygen GmbH Press release Berlin, January 27, 2021 The longevity gene mINDY (I’m Not Dead, Yet) not [...]
October 2020 – Eternygen Announces the First Closing of its Series A2 Funding Round
Eternygen Announces the First Closing of its Series A2 Funding Round
April 2020 – Eternygen is presenting at „BioLaunchPad, the company showcase platform of BioTrinity” from 28 April – 1 May 2020.
Eternygen is presenting at „BioLaunchPad, the company showcase platform of BioTrinity” from 28 April – 1 May 2020. Link
March 2020 – Dr. Grit Zahn, Head of Research of Eternygen GmbH presents at the 4th International SLC13A5 Deficiency Research Roundtable of the Tess research foundation in March 2020.
Dr. Grit Zahn, Head of Research of Eternygen GmbH presents at the 4th International SLC13A5 Deficiency Research Roundtable of the […]
February 2020 – Eternygen Presents Data Demonstrating INDY Inhibition as Novel Therapeutic Option in NASH
Eternygen Presents Data Demonstrating INDY Inhibition as Novel Therapeutic Option in NASH Press statement
Meet Eternygen at the Biotech Showcase conference 2020 in San Francisco, CA, USA
Meet Eternygen at the Biotech Showcase conference 2020 in San Francisco, CA, USA Eternygen is attending the Biotech Showcase conference […]
Meet Eternygen at BioEurope conference in Hamburg from November 11th to 13th 2019
Meet Eternygen at BioEurope conference in Hamburg from November 11th to 13th Eternygen will attend the BioEurope conference in Hamburg […]
Prof. Birkenfeld publishes new review on Transporters as Drug Targets titled „Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.”
Prof. Birkenfeld publishes new review on Transporters as Drug Targets titled „Solute Carrier Transporters as Potential Targets for the Treatment […]
Prof. Birkenfeld publishes new review on NAFLD
Prof. Birkenfeld publishes new review on NAFLD (Link to Paper)
Prof. Birkenfeld was appointed as Chair of Medicine and Director of the Department of Diabetology, Endocrinology and Nephrology at the University Clinic Tübingen
Prof. Birkenfeld was appointed as Chair of Medicine and Director of the Department of Diabetology, Endocrinology and Nephrology at the […]
Prof. Birkenfeld was awarded with the Abstract Award
Prof. Birkenfeld was awarded with the Abstract Award Prof. Birkenfeld was awarded with the Abstract Award by the American College […]
Prof. Birkenfeld in Sächsische Zeitung
Prof. Birkenfeld in Sächsische Zeitung Prof. Birkenfeld in Sächsische Zeitung with the topic “How your lifestyle advances diabetes”. (Article in […]
Prof. Birkenfeld publishes new INDY (I’m Not Dead Yet) review
Prof. Birkenfeld publishes new INDY (I’m Not Dead Yet) review Prof. Birkenfeld publishes new INDY (I’m Not Dead Yet) review […]
Eternygen at BioFIT 2017
Eternygen at BioFIT 2017 Eternygen was invited to join panel discussion at BioFIT 2017 conference “How are collaborations key to […]
Prof. Birkenfeld is chairman of the working group diabetes and heart
Prof. Birkenfeld is chairman of the working group diabetes and heart Prof. Birkenfeld is the new chairman of the working […]
Eternygen GmbH is part of the Network for Pharma Solutions (NetPhaSol, Germany)
Eternygen GmbH is part of the Network for Pharma Solutions (NetPhaSol, Germany) Press release
Prof. Birkenfeld visiting expert at MDR Sachsen radio
Prof. Birkenfeld visiting expert at MDR Sachsen radio Prof. Birkenfeld visiting expert at MDR Sachsen radio talking about cholesterol (in German)
Prof. Birkenfeld in expert discussion with MDR1 radio
Prof. Birkenfeld in expert discussion with MDR1 radio Discussion about “Sugar as a drug” (in German)
